Evidence map›Paper›PMID 25922769›Full record

ArticleCase reports in genetics2015

Incidental Finding of a Homozygous p.M348K Asymptomatic Italian Patient Confirms the Many Faces of Cystic Fibrosis.

Rossana Molinario, Sara Palumbo, Paola Concolino, Sandro Rocchetti, Roberta Rizza, Giovanni Luca Scaglione, Angelo Minucci, Ettore Capoluongo

Open access · goldAbstract read
In one paragraph

Article in Case reports in genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rossana MolinarioLaboratory of Clinical Molecular and Personalized Diagnostics, Department of Laboratory Medicine, University Hospital "A. Gemelli", 8 Largo A. Gemelli, 00168 Rome, Italy.
Sara PalumboLaboratory of Clinical Molecular and Personalized Diagnostics, Department of Laboratory Medicine, University Hospital "A. Gemelli", 8 Largo A. Gemelli, 00168 Rome, Italy.
Paola ConcolinoLaboratory of Clinical Molecular and Personalized Diagnostics, Department of Laboratory Medicine, University Hospital "A. Gemelli", 8 Largo A. Gemelli, 00168 Rome, Italy.
Sandro RocchettiLaboratory of Clinical Molecular and Personalized Diagnostics, Department of Laboratory Medicine, University Hospital "A. Gemelli", 8 Largo A. Gemelli, 00168 Rome, Italy.
Roberta RizzaLaboratory of Clinical Molecular and Personalized Diagnostics, Department of Laboratory Medicine, University Hospital "A. Gemelli", 8 Largo A. Gemelli, 00168 Rome, Italy.
Giovanni Luca ScaglioneLaboratory of Clinical Molecular and Personalized Diagnostics, Department of Laboratory Medicine, University Hospital "A. Gemelli", 8 Largo A. Gemelli, 00168 Rome, Italy.
Angelo MinucciLaboratory of Clinical Molecular and Personalized Diagnostics, Department of Laboratory Medicine, University Hospital "A. Gemelli", 8 Largo A. Gemelli, 00168 Rome, Italy.
Ettore CapoluongoLaboratory of Clinical Molecular and Personalized Diagnostics, Department of Laboratory Medicine, University Hospital "A. Gemelli", 8 Largo A. Gemelli, 00168 Rome, Italy.
Agostino Gemelli University Polyclinic · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF; OMIM number 219700) is an autosomal recessive disease caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which results in abnormal viscous mucoid secretions in multiple organs and whose main clinical features are pancreatic insufficiency, chronic endobronchial infection, and male infertility. We report the case of a 47-year-old apparently normal male resulting in homozygosity for the mutation p.M348K from nonconsanguineous parents. The proband was screened using a standard panel of 70 different tested on NanoChip 400 platform. The massive parallel pyrosequencing on 454 JS machine allowed the second level analysis. The patient was firstly screened with two different platforms available in our laboratory, obtaining an ambiguous signal for the p.R347P mutation. For this reason we decided to clarify the discordant result of CFTR status by Next Generation Sequencing (NGS) using 454 Junior instrument. The patient is resulted no carrier of the p.R347P mutation, but NGS highlighted a homozygous substitution from T>A at position 1043 in the coding region, causing an amino acid substitution from methionine to lysine (p.M348K). Casual finding of p.M348K homozygote mutation in an individual, without any feature of classical or nonclassical CF form, allowed us to confirm that p.M348K is a benign rare polymorphism.

Identifiers

PMID25922769
PMCPMC4397493
OpenAlexW2053334313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.